Mexico Researchers Inhibit Cancer Cells with Substance Obtained from Marine Sponge Medical Xpress
go to original May 5, 2015

For more than three decades, no new drug for the treatment of breast cancer has been presented. A group of researchers analyzing a marine sponge called Halichondrin okadai obtained a mesylate eribulin substance that had already been administered to patients with metastatic breast cancer.

Claudia Arce Salinas from the National Cancer Institute (INCan) in Mexico, and professor at the School of Medicine of the National Polytechnic Institute, explained that she worked in Japan with the marine sponge because scientists realized that it inhibited the replication of organisms around it.

..."This medicine does not require premedication. As it is essentially chemotherapy, side effects are similar to chemo and radiation treatments. However, it prolongs the life of women 1,500 times over standard conventional treatments, " said the specialist.

The drug has already been approved in Mexico, and in 2011 by the FDA in the United States. At first, it will be administered in the private sector and in short time in the public one.

"There are several Mexican candidates for treatment in various institutions because breast cancer is the second cause of death among women between 30 and 54 years of age."

Read the rest at Medical Xpress

We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!